Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Translating pharmacogenetics to primary care | Swen J.J., PhD | Guchelaar H.J., prof. dr. | Assendelft W.J.J., prof. dr. | Wessels J.A.M., dr. | Universiteit Leiden (UL) | 2011 | Pharmacogenetics; Primary care; | |
Individualized dosing of calcineurin inhibitors in renal transplantation | Press R.R., PhD | Guchelaar H.J., prof. dr. | Fijter J.W. de, prof. dr. | Ploeger B.A., dr. | Universiteit Leiden (UL) | 2011 | Kidney; Transplantation; Calcineurin inhibitors; | |
Treatment response in childhood asthma | Vijverberg S.J.H., PhD | Raaijmakers J.A.M., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2014 | Treatment outcomes; Children; Asthma; | ||
Towards better treatment outcomes in childhood asthma | Koster E.S., PhD | Raaijmakers J.A.M., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2011 | Asthma; Children; Treatment Outcomes; Epidemiology; | ||
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
Natriuretic peptides, diagnostics and prognostic biomarkers | Rutte J.H.W., dr. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2010 | Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system; | ||
Neurovascular pharmacology of prospective antimigraine drugs | Chan K.Y., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Migraine; Neurovascular pharmacology; | ||
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
Red wine polyphenols and vascular function | Botden I.P.G., PhD | Danser A.H.J., prof. dr. | Sijbrands E.J.G., prof. dr. | Langendonk J.G., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Antihypertensive drugs; Cardiovascular disease; Pharmacology; | |
Vascular aging from DNA damage to protection | Ďurik M., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Cardiovascular disease; Pharmacology; | ||
The role of aldosterone and aldosterone blockade in hypertension | Jansen P.M., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Cardiovascular disease; Antihypertensive drugs; Pharmacology; | |||
Neurovascular pharmacology of migraine: epigenetics and sex hormones | Labruijere S., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology; | ||
Novel directions in therapy against age-related vascular disease | Wu H., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Cardiovascular disease; | ||
The alternative renin-angiotensin system: exploration of its therapeutic potential | Sevá Pessôa B., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | ||
The (pro)renin receptor: moving away from prorenin? | Lu X., PhD | Danser A.H.J., prof. dr. | Meima M.E., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Pharmacology; Prorenin; | ||
Preeclampsia, the renin-angiotensin-aldosterone system and beyond | Verdonk K., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system; | |||
Integrated pharmaceutical care: cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan | Geurts M.M.E., PhD | Gier J.J. de, prof. dr. | Brouwers J.R.B.J., prof. dr. | Graeff P.A. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
Medication safety in Vietnamese hospital: a focus on medication errors and safety culture | Nguyen T.H., PhD | Taxis K., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Brouwers J.R.B.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | ||
Driving-impairing medicines and traffic safety: patients' perspectives | Monteiro S.P., PhD | Gier J.J. de, prof. dr. | Dijk C.E.M.J. van, dr. ir. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Minimally invasive methodology for pharmacological research involving children | Klein R.H., PhD | Cohen A.F., prof. dr. | Burggraaf J., prof. dr. | Sukhai R.N., dr. | Universiteit Leiden (UL) | 2013 | Paediatrics; Clinical pharmacology; ADHD; Pharmacokinetics; Growth hormone deficiency; Pharmacodynamics; Point of care technology; | |
Neuropharmacology of novel dopamine modulators | Beek E.T te, PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Dopamine Antagonist Drug development Pharmacokinetics Pharmacodynamics Schizophrenia Drug addiction Tachykinins | ||
Non-invasive monitoring of pharmacokinetics and pharmacodynamics for pharmacological drug profiling in children and adolescents | Schrier L., PhD | Cohen A.F., prof. dr. | Gerven J.M.A. van, prof. dr. | Sukhai R.N., dr. | Universiteit Leiden (UL) | 2015 | Non-invasive monitoring; Pharmacokinetics; Pharmacodynamics; Pharmacological drug profiling; Children; Adolescents; | |
Drug-induced psychomimetic symptoms as a model for psychosis | Kleinloog-Fernández González H.D., PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Clinical Pharmacology Psychotic Disorders Clinical Trial Drug evaluation Biological Models | ||
Exploring the role of glucagon in glucose homeostasis | Dongen M.G.J. van, PhD | Cohen A.F., prof. dr. | Romijn J.A., prof dr | Burggraaf J., prof. dr. | Universiteit Leiden (UL) | 2015 | Glucagon; Diabetes mellitus; Glucose homeostasis; Glucagon challenge; Glucagon receptor antagonist; Insulin | |
Novel approaches in clinical development of cannabinoid drugs | Klumpers L.E., PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Cannabinoids; THC; CB1 antagonists; Pharmacokinetics; Clinical pharmacology; Pharmacodynamics; Feeling high; PK-PD modelling; Resting state FMRI; Rimonabant; | ||
Cognition in Huntington's disease : the influence of motor behaviour and time | Hart E.P. 't, PhD | Roos R.A.C., prof. dr. | Universiteit Leiden (UL) | 2013 | Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour | |||
The road to tailor made azole antifungal therapy | Brüggemann R.J.M., PhD | Burger D.M., prof. dr. | Verweij P.E., prof. dr. | Blijlevens N.M.A., dr. | Radboud Universiteit (RU) | 2011 | Antifungal; clinical pharmacology | |
Clinical pharmacology of nevirapine in HIV-infected patients in Tanzania | Muro E.P., PhD | Burger D.M., prof. dr. | Dolmans W.M.V., prof. dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring | ||
Assessment of ischaemia and reperfusion injury | Wouters C.W., PhD | Rongen G.A., prof. dr. | Oyen W.J.G., prof. dr. | Radboud Universiteit (RU) | 2013 | Ischemia/reperfusion injury; adenosine; atorvastatin; forearm; | ||
The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease | Weigand K.M., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
New insights into the role of breast cancer resistance protein in endocrine and metabolic processes | Dankers A.C.A., PhD | Russel F.G.M., prof. dr. | Sweep C.G.J., prof. dr. | Masereeuw R., prof. dr. | Radboud Universiteit (RU) | 2014 | Cancer; Breast cancer; | |
Vascular adaptation to pregnancy and relaxin | Drongelen J. van, PhD | Smits P., prof. dr. | Lotgering F.K., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
Medication safety through information technology; a focus on medication prescribing and administering. | Helmons P.J., PhD | Kosterink J.G.W., prof. dr. | Daniels C.E., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | medication safety information technology prescribing and administering drugs | ||
Loss of proteostasis as a substrate for Atrial Fibrilation. | Meijering R.A.M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | Atrial fibrillation; Proteostasis; | ||
Patient perspectives in the benefit-risk evaluation of drugs | Vries S.T. de, PhD | Denig P., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Zeeuw D. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practice | Dugbartey G.J., PhD | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 2015 | |||
The influence of the sample matrix on LC-MS/MS method development and analytical performance | Koster R.A., PhD | Uges D.R.A., prof. dr. | Kosterink J.G.W., prof. dr. | Alffenaar J.W.C., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation | Wiersma M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Atrial fibrillation; | ||
Novel biomarker panels in diabetic kidney disease: predicting disease progression and response to therapy, and monitoring drug effect | Pena M.J., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Biomarkers; Diabetes mellitus; Kidney; | ||
Immunological aspects of hibernation as leads in the prevention of acute organ injury. | Bouma H.R., PhD | Henning R.H., prof. dr. | Kroese F.G.M., prof. dr. | Strijkstra A.M., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | hibernation acute organ injury immunological | |
Statin treatment in type 2 diabetes patiënts | Vries F.M. de, PhD | Hak E., prof. dr. | Denig P., prof. dr. | Postma M.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Statins; Diabetes mellitus; | |
Drug-related problems: risk factors and the role of clinical pharmacists | Zaal R.J., PhD | Vulto A.G., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Bemt P.M.L.A. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2016 | Drug-related problems; Risk factors; | |
Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicine | Schievink B.H., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | PRE score; Risk markers; Chronic kidney disease; Personalized medicine; | ||
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimates | Kröpelin T.F., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Kidney; Diabetic kidney disease; Drug efficacy; |
Go to page:
- of 6
- >